Company intelligence / Profile preview

Renaissance Health Publishing

Boca Raton, Florida, United States

Ownership: Private
Development stage: Other

Overview

The company marketed the dietary supplement Isoprex directly to consumers, claiming it could relieve pain and joint inflammation in older adults, but the FTC found the claims unsubstantiated and obtained a settlement barring such claims and providing refunds to purchasers.[9]

Therapeutic areas: ImmunologyRheumatology
Modalities: Small moleculeNon-pharmacological therapyNutraceutical
Industry: Food & Nutrition

Beyond the preview

Go deeper on Renaissance Health Publishing.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renaissance Health Publishing.

Explore the full profile